Boston Scientific announced yesterday that it’s halting sales of its implantable cardioverter defibrillators (ICDs). The suspension was due to filing errors and not safety issues, but the company says it still has no idea how long the suspension will last. For a firm fighting to recover back to former glory, this is another setback. Yet, […]
Author Archives: Jason Kelly
1149.99
If you were a prankster of a market index and wanted to mess with every investor for fun, you would have behaved last week exactly as the S&P; 500 behaved. The bulls were getting their party poppers ready a week ago to celebrate crossing over the 1150 line, as they anticipated doing last week. Bears […]
The 1150 Ceiling
Have you noticed the S&P; 500’s range? Many have not. A lot of analysts I read, and media I watch, keep referring to the stock market rally as being one year old. Is it really, though? Consider that the first 49% of the bounce happened by last July. The S&P; 500 rebounded from its 667 […]
Bouchier Solves The Health Care Crisis
I subscribe to David Bouchier’s witty podcast, and find it to be one of the week’s most pleasant listens as I cycle over nearby mountains to keep myself in shape and out of the doctor’s office. It’s a gentle break from the cacophany of political and financial programs. While most of those are dry with […]
Hedging Against Cheaper Oil
Maria asked, “Do you think the price of oil is about to spike higher because Israel and the U.S. will soon attack Iran to stop it from making a nuclear bomb? If so, do you recommend that I buy oil company stocks, or an oil ETF?” No to the first question and, thus, no to […]





